Drug
Leo 90105
Leo 90105: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 90105 NCT01293357 | Phase 1 | Healthy |
Latest
No recent events.
Follow Leo 90105 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.